HIGHLIGHTS
- who: Teena Chopra from the University of Zaragoza, Spain have published the Article: Gut microbiota and microbiota-based therapies for Clostridioides difficile infection, in the Journal: (JOURNAL) of November/30,/2022
- future: Approaches to restoring the gut microbiota Live biotherapeutic products (LBPs) have been developed as an extension of the initial FMT studies in part as a way to standardize products and outcomes being measured.
SUMMARY
Clostridioides difficile infection (CDI) is an urgent threat, both for the patient and healthcare professionals. Testing for CDI is recommended for patients who have unexplained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.